Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
21 11 2021
Historique:
received: 14 01 2021
revised: 01 03 2021
accepted: 23 04 2021
pubmed: 27 5 2021
medline: 15 12 2021
entrez: 26 5 2021
Statut: ppublish

Résumé

To provide multi-national, multi-ethnic data on the clinical characteristics and prognosis of patients with microvascular angina (MVA). The Coronary Vasomotor Disorders International Study Group proposed the diagnostic criteria for MVA. We prospectively evaluated the clinical characteristics of patients according to these criteria and their prognosis. The primary endpoint was the composite of major cardiovascular events (MACE), verified by institutional investigators, which included cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and hospitalization due to heart failure or unstable angina. During the period from 1 July 2015 to 31 December 2018, 686 patients with MVA were registered from 14 institutes in 7 countries from 4 continents. Among them, 64% were female and the main ethnic groups were Caucasians (61%) and Asians (29%). During follow-up of a median of 398 days (IQR 365-744), 78 MACE occurred (6.4% in men vs. 8.6% in women, P = 0.19). Multivariable Cox proportional hazard analysis disclosed that hypertension and previous history of coronary artery disease (CAD), including acute coronary syndrome and stable angina pectoris, were independent predictors of MACE. There was no sex or ethnic difference in prognosis, although women had lower Seattle Angina Questionnaire scores than men (P < 0.05). This first international study provides novel evidence that MVA is an important health problem regardless of sex or ethnicity that a diagnosis of MVA portends a substantial risk for MACE associated with hypertension and previous history of CAD, and that women have a lower quality of life than men despite the comparable prognosis.

Identifiants

pubmed: 34038937
pii: 6284114
doi: 10.1093/eurheartj/ehab282
pmc: PMC8633728
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4592-4600

Subventions

Organisme : Medical Research Council
ID : MR/N003403/1
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : British Heart Foundation
ID : PG/17/2532884
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/6134217
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Eur Heart J. 2014 May;35(17):1101-11
pubmed: 24366916
Int J Cardiol Heart Vasc. 2020 Sep 11;31:100630
pubmed: 32984497
J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32
pubmed: 20579539
Eur Heart J. 2003 Nov;24(22):1999-2005
pubmed: 14613735
Am Heart J. 2001 Nov;142(5):864-71
pubmed: 11685176
N Engl J Med. 2016 Mar 24;374(12):1167-76
pubmed: 27007960
Cardiovasc Res. 2020 Mar 1;116(4):806-816
pubmed: 31999329
Eur Heart J. 2018 Mar 14;39(11):952-959
pubmed: 29165549
Circulation. 2004 Jan 6;109(1):53-8
pubmed: 14699004
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
N Engl J Med. 2010 Mar 11;362(10):886-95
pubmed: 20220183
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2841-2855
pubmed: 30266608
Eur Heart J. 2014 Dec 1;35(45):3180-93
pubmed: 25354517
Am J Cardiol. 1988 Jun 1;61(15):1338-43
pubmed: 3287885
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1423-1433
pubmed: 30093048
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Int J Cardiol. 2018 Jan 1;250:16-20
pubmed: 29031990
Circulation. 2017 Mar 14;135(11):1075-1092
pubmed: 28289007
Cardiovasc Res. 2020 Mar 1;116(4):856-870
pubmed: 32087007
J Am Coll Cardiol. 2019 Nov 12;74(19):2350-2360
pubmed: 31699275
N Engl J Med. 2007 Feb 22;356(8):830-40
pubmed: 17314342
J Am Coll Cardiol. 1995 Feb;25(2):333-41
pubmed: 7829785
Eur Heart J. 2012 Oct;33(20):2551-67
pubmed: 22922414
Am J Cardiol. 1989 Feb 1;63(5):286-90
pubmed: 2643845
Nat Rev Cardiol. 2015 Jan;12(1):48-62
pubmed: 25311229
Int J Cardiol. 1995 Nov 24;52(2):135-43
pubmed: 8749873
J Am Coll Cardiol. 1995 Mar 15;25(4):807-14
pubmed: 7884081

Auteurs

Hiroaki Shimokawa (H)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Sendai, Japan.
International University of Health and Welfare, Narita, Japan.

Akira Suda (A)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Sendai, Japan.

Jun Takahashi (J)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Sendai, Japan.

Colin Berry (C)

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.

Paolo G Camici (PG)

Vita Salute University and San Raffaele Hospital, Milan, Italy.

Filippo Crea (F)

Department of Cardiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Javier Escaned (J)

Department of Cardiology, Hospital Clínico San Carlos IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

Tom Ford (T)

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.

Eric Yii (E)

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.

Juan Carlos Kaski (JC)

Department of Cardiovascular Science, Cardiovascular and Cell Sciences Res Institute, St George's, University of London, UK.

Takahiko Kiyooka (T)

Department of Cardiology, Tokai University Oiso Hospital, Oiso, Japan.

Puja K Mehta (PK)

Department of Medicine, Division of Cardiology, Emory University, Atlanta, GA, USA.

Peter Ong (P)

Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.

Yukio Ozaki (Y)

Department of Cardiology, Fujita Health University School of Medicine, Toyonaka, Aichi, Japan.

Carl Pepine (C)

Division of Cardiovascular Medicine, University of Florida, College of Medicine, Gainesville, FL, USA.

Ornella Rimoldi (O)

Institute of Molecular Bioimaging and Physiology, Consiglio Nazionale delle Ricerche, Segrate, Italy.

Basmah Safdar (B)

Department of Emergency Medicine, Yale University, New Haven, CT, USA.

Udo Sechtem (U)

Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Sendai, Japan.

John F Beltrame (JF)

The Discipline of Medicine, University of Adelaide, Basil Hetzel Institute, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.

C Noel Bairey Merz (CNB)

Department of Cardiology, Cedars-Sinai Medical Center, Barbra Streisand Women's Heart Center, Smidt Heart Institute, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH